亚太地区羊膜市场预测至 2027 年 - COVID-19 影响和酶区域分析(冷冻羊膜和脱水羊膜);应用(手术伤口、眼科等);最终用户(医院、门诊手术中心、专科诊所、研究所和学术机构)和国家/地区

Historic Data: 2017-2018   |   Base Year: 2019   |   Forecast Period: 2020-2027


No. of Pages: 69    |    Report Code: TIPRE00014179    |    Category: Life Sciences

Asia Pacific Amniotic Membrane Market

市场介绍

羊膜是胎盘的最内层,有利于胎儿的发育。羊膜移植作为软组织重新生长的基础,有助于伤口愈合。它在多种环境中用作皮肤替代品和外科生物材料,例如各种病理状况的临床治疗。

市场概况和动态

亚太地区羊膜市场预计将从2019年的2.7928亿美元增至2027年的5.0369亿美元。预计2020-2027年该市场将以7.8%的复合年增长率增长。推动市场增长的因素是羊膜应用的增加和目标患者群体数量的增加。然而,使用羊膜的挑战可能会限制预测期内的市场增长。

 

主要细分市场

按酶计,冷冻羊膜细分市场在 2019 年占据最大市场份额,而脱水羊膜细分市场预计在预测期内的复合年增长率最高。从应用来看,2019年手术伤口领域占据最大市场份额;此外,预计该细分市场在预测期内将达到市场上最高的复合年增长率。在最终用户细分市场中,医院细分市场在2019年占据了最大的市场份额。此外,预计门诊手术中心细分市场在预测期内的复合年增长率最高。

 

主要来源和上市公司

亚太羊膜市场的一些主要一手和二手来源包括报告中的机构包括世界卫生组织 (WHO)、国家医院流动医疗中心、印度医学研究委员会等。

购买该报告的理由

  • 了解亚太地区羊膜市场范围并确定最有可能的细分市场确保丰厚的回报
  • 了解亚太羊膜市场不断变化的竞争格局,保持领先地位
  • < span>通过识别最有可能销售的细分市场,有效规划亚太羊膜市场的并购和合作交易
  • 帮助通过敏锐和全面的分析做出明智的业务决策亚太地区羊膜市场各个细分市场的市场表现
  • 获取亚太地区2019年至2027年各个细分市场的市场收入预测。


 

亚太羊膜膜市场–

羊膜市场–通过酶

  • 冷冻羊膜
  • 脱水羊膜

 

羊膜市场–按应用

  • 手术伤口
  • 眼科
  • 其他

 

羊膜市场 –按最终用户划分

  • 医院
  • 门诊手术中心
  • 专科诊所
  • 研究机构和学术机构
  • < /ul>

     

    羊膜市场 - 按

    国家

      < li>中国
    • 日本
    • 印度
    • 澳大利亚
    • 韩国

     

    公司简介

    • Amniox Medical, Inc.
    • Integra Life Sciences Corporation
    • MiMedx
    • Organogenesis Inc.
    • 史密斯&amp;侄子


    Asia Pacific Amniotic Membrane Strategic Insights

    Strategic insights for Asia Pacific Amniotic Membrane involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

    strategic-framework/asia-pacific-amniotic-membrane-market-strategic-framework.webp
    Get more information on this report

    Asia Pacific Amniotic Membrane Report Scope

    Report Attribute Details
    Market size in 2019 US$ 279.28 Million
    Market Size by 2027 US$ 503.69 Million
    Global CAGR (2020 - 2027) 7.8%
    Historical Data 2017-2018
    Forecast period 2020-2027
    Segments Covered By 酶
    • 冻存羊膜
    • 脱水羊膜
    By 应用
    • 外科伤口
    • 眼科
    By 最终用户
    • 医院
    • 门诊手术中心
    • 专科诊所
    • 研究机构
    • 学术机构
    Regions and Countries Covered 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 亚太其他地区
    Market leaders and key company profiles
  • Amniox Medical, inc
  • Integra Life Sciences Corporation
  • MiMedx
  • Organogenesis Inc.
  • Smith & Nephew
  • Get more information on this report

    Asia Pacific Amniotic Membrane Regional Insights

    The regional scope of Asia Pacific Amniotic Membrane refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/asia-pacific-amniotic-membrane-market-geography.webp
    Get more information on this report

The List of Companies - Asia Pacific Amniotic Membrane Market

The List of Companies - Asia Pacific Amniotic Membrane Market

  1. Amniox Medical, inc
  2. Integra Life Sciences Corporation
  3. MiMedx
  4. Organogenesis Inc.
  5. Smith & Nephew
Frequently Asked Questions
How big is the Asia Pacific Amniotic Membrane Market?

The Asia Pacific Amniotic Membrane Market is valued at US$ 279.28 Million in 2019, it is projected to reach US$ 503.69 Million by 2027.

What is the CAGR for Asia Pacific Amniotic Membrane Market by (2020 - 2027)?

As per our report Asia Pacific Amniotic Membrane Market, the market size is valued at US$ 279.28 Million in 2019, projecting it to reach US$ 503.69 Million by 2027. This translates to a CAGR of approximately 7.8% during the forecast period.

What segments are covered in this report?

The Asia Pacific Amniotic Membrane Market report typically cover these key segments-

  • 酶 (冻存羊膜, 脱水羊膜)
  • 应用 (外科伤口, 眼科)
  • 最终用户 (医院, 门诊手术中心, 专科诊所, 研究机构, 学术机构)
  • What is the historic period, base year, and forecast period taken for Asia Pacific Amniotic Membrane Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Amniotic Membrane Market report:

  • Historic Period : 2017-2018
  • Base Year : 2019
  • Forecast Period : 2020-2027
  • Who are the major players in Asia Pacific Amniotic Membrane Market?

    The Asia Pacific Amniotic Membrane Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Amniox Medical, inc
  • Integra Life Sciences Corporation
  • MiMedx
  • Organogenesis Inc.
  • Smith & Nephew
  • Who should buy this report?

    The Asia Pacific Amniotic Membrane Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Amniotic Membrane Market value chain can benefit from the information contained in a comprehensive market report.